Tobacco plants may provide virus cure

Feb 01, 2008
Tobacco plants may provide virus cure

Scientists from ASU’s Biodesign Institute and Polytechnic campus have embarked on an ambitious, four-year, $1.5 million grant from the National Institutes for Allergy and Infectious Disease to tackle West Nile virus.

The virus, which is spread by infected mosquitoes, can be a serious, life-altering – and even fatal – disease.

There is no current cure or drug treatment against West Nile virus, which in 2007 afflicted more than 3,500 people in the United States, resulting in 109 fatalities.

Qiang “Shawn” Chen, a researcher in the institute’s Center for Infectious Diseases and Vaccinology, and assistant professor at the Polytechnic campus’ Department of Applied Biological Sciences, will lead the interdisciplinary research project that will use tobacco plants to produce novel therapeutic agents against the virus. Participants in the project include fellow Biodesign and Polytechnic campus colleagues, and scientists from Washington University in St. Louis.

“Through the leadership of Charles Arntzen, our group has assembled some of world’s greatest research expertise in plant-based vaccines and therapeutics, and now we want to apply that knowledge to address the leading mosquito-borne health threat in the United States,” Chen says.

The plant-made pharmaceutical group at ASU has demonstrated research success on a variety of plant-based vaccines, including the first U.S. regulatory approved-plant based vaccine against a poultry infection, Newcastle’s disease.

In the West Nile project, the team’s goal is to have the plants produce antibodies against the virus in the hopes of neutralizing and destroying the virus before it can trigger its harmful effects.

“One of the challenges for this particular – or for any – central nervous system-related disease is that, after the infection, in a few days the virus will get into the central nervous system and get past the blood-brain barrier,” Chen says.

This microscopic biological filter acts as the brain’s chief defense mechanism against unwanted substances from entering the brain. But during infection, the virus manages to bypass and infect the brain while unfortunately keeping out potential therapeutics.

“The antibodies we are developing have good binding features against the virus,” Chen says. “But my approach to this question is to try to make them better, and get the therapeutic past the blood-brain barrier so that people who have been infected beyond the initial treatment window still have hope.”

The therapeutic “plantibodies” designed to target West Nile virus will be produced in an innovative tobacco system.

To make the potential therapeutics, the group is able to use young tobacco plants, infiltrate them with a protein expression system, and harvest the potential therapeutics in the leaves.

It takes as little as 10 days to harvest the material from the plants.

Chen hopes to provide proof of concept of the approach in the next one to two years and prove efficacy and safety of the technology by the end of the funding period.

“We want to take what we’ve learned during the grant period with the ultimate goal of entering clinical trials,” he says.

Source: ASU

Explore further: Biomedical engineer looks at new applications for novel lupus drug

add to favorites email to friend print save as pdf

Related Stories

How Kindle Unlimited compares with Scribd, Oyster

12 hours ago

Amazon is the latest—and largest—company to offer unlimited e-books for a monthly fee. Here's how Kindle Unlimited, which Amazon announced Friday, compares with rivals Scribd and Oyster.

NASA sees powerful thunderstorms in Tropical Storm Matmo

12 hours ago

Strong thunderstorms reaching toward the top of the troposphere circled Tropical Storm Matmo's center and appeared in a band of thunderstorms on the storm's southwestern quadrant. Infrared imagery from NASA's ...

ISS 'space truck' launch postponed: Arianespace

14 hours ago

The July 24 launch of a robot ship to deliver provisions to the International Space Station has been postponed "for a few days", space transport firm Arianespace said Friday.

Recommended for you

Monitoring the rise and fall of the microbiome

7 hours ago

Trillions of bacteria live in each person's digestive tract. Scientists believe that some of these bacteria help digest food and stave off harmful infections, but their role in human health is not well understood.

Antioxidant biomaterial promotes healing

14 hours ago

When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative ...

Immune response may cause harm in brain injuries, disorders

17 hours ago

Could the body's own immune system play a role in memory impairment and cognitive dysfunction associated with conditions like chronic epilepsy, Alzheimer's dementia and concussions? Cleveland Clinic researchers believe so, ...

User comments : 0